HCPCS M0232 — Inf tocilizumab-bavi 2nd dos (2026 RVU Values)
HCPCS code M0232 (Inf tocilizumab-bavi 2nd dos) is published in the 2026 CMS Physician Fee Schedule. Use this page as a reference for billing, productivity tracking, and compensation modeling.